We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Home > News > Science & Health

World-first Cannabis Trial Looks to Treat Insomnia

Published: Apr 30, 2018   

Complete the form below and we will email you a PDF version of "World-first Cannabis Trial Looks to Treat Insomnia"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

World-first Cannabis Trial Looks to Treat Insomnia

Credit: Sadie Hernandez on Flickr

In a world-first study, researchers at The University of Western Australia will examine the effect medicinal cannabis has on adults suffering from chronic insomnia.


Around one in three Australians has regular difficulty getting to sleep or staying asleep and it is believed the sedation effect brought on by medicinal cannabis could be an alternative treatment for those experiencing the condition. 


The study will be coordinated through the UWA Centre for Sleep Science using a cannabinoid extract provided by Zelda Therapeuatics, an Australian medical research and development company.  


UWA Study lead Professor Peter Eastwood said current evidence suggested medicinal cannabis could be a less invasive alternative to current drugs on the market. 


“Prescription medicines such as benzodiazepines (e.g. Temazepam), non-benzodiazepine hypnotics (e.g.Stilnox, Sonata, Imovane) and some antidepressants and antihistamines can have unpleasant side effects and when used long-term can result in dependence and withdrawal symptoms,” Professor Eastwood said.


“Based on previous research we believe a small dose of medicinal cannabinoid may be effective for treating chronic insomnia and have fewer side effects than current drug treatment options.”


The study involves participants taking either a medicinal cannabinoid for two weeks or a ‘placebo’ with no active ingredients and then completing a series of assessments and questionnaires relating to how they slept.


The participants will then crossover the medications for another two weeks and return again for the same assessments. They won’t know the order in which they receive the ‘active’ or ‘placebo’ medication.  


This article has been republished from materials provided by The University of Western Australia. Note: material may have been edited for length and content. For further information, please contact the cited source.

 

Like what you just read? You can find similar content on the topic tag shown below.

Science & Health

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement